# Neuromodulation in COVID-19 Patients

> **NCT04808284** · PHASE1,PHASE2 · COMPLETED · sponsor: **D'Or Institute for Research and Education** · enrollment: 60 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** Transcranial direct-current stimulation
- **DEVICE:** Transcranial direct-current stimulation
- **DEVICE:** Sham Transcranial direct-current stimulation

## Key facts

- **NCT ID:** NCT04808284
- **Lead sponsor:** D'Or Institute for Research and Education
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-10
- **Primary completion:** 2021-10-11
- **Final completion:** 2021-10-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-10-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04808284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04808284, "Neuromodulation in COVID-19 Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04808284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*